0000899243-19-019342.txt : 20190708
0000899243-19-019342.hdr.sgml : 20190708
20190708213217
ACCESSION NUMBER: 0000899243-19-019342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190703
FILED AS OF DATE: 20190708
DATE AS OF CHANGE: 20190708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Satvat Ali J.
CENTRAL INDEX KEY: 0001621788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 19946239
MAIL ADDRESS:
STREET 1: C/O KOHLBERG KRAVIS ROBERTS & CO.
STREET 2: 2800 SAND HILL ROAD, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-03
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001621788
Satvat Ali J.
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO
CA
94104
1
0
1
0
Common Stock
2019-07-03
4
P
0
882353
29.9005
A
24575501
I
See Footnote
The shares are owned by BridgeBio Pharma LLC. The Reporting Person is a member of the board of managers of BridgeBio Pharma LLC and may be deemed to beneficially own the shares held by BridgeBio Pharma LLC. The Reporting Person disclaims beneficial ownership of the shares for Section 16 purposes or for any other purpose, except to the extent of his pecuniary interest therein.
/s/ Franco Valle, as Attorney-in-Fact
2019-07-08